当前我国正在加快构建双循环新发展格局,统筹发展与安全,推动实现经济高质量发展,在这一背景下,推动我国医药流通行业高质量发展有助于加快完善现代流通体系,有助于保障居民用药安全,提升国民健康水平,以及提升我国医药供应链安全性、稳定性、可持续性。近些年我国医药流通行业得到稳步发展,规模逐步扩大,结构不断优化,政策体系持续完善,但同时也需要进一步提升医药供应链服务的专业化、规范化、标准化水平,进一步完善医药流通供应链主数据管理信息系统,进一步优化医药物流网络布局,提高各省份医药流通监管政策一致性等。未来需要以医药流通企业提升服务价值、降低服务成本为根本出发点和落脚点,由政府、行业协会、企业多主体协作,大力推进医药流通行业服务创新,更好地助力医药流通行业服务提质降本增效,实现高质量发展。
<<At present,China is accelerating the construction of a new development pattern of double circulation,coordinating development and safety,and promoting the realization of high-quality economic development. In this context,promoting the high-quality development of China’s pharmaceutical circulation industry will help accelerate the improvement of the modern circulation system,help to ensure the safety of residents’ medication,improve the national health level,and improve the security,stability and sustainability of China’s pharmaceutical supply chain. In recent years,China’s pharmaceutical circulation industry has developed steadily,the scale has been gradually expanded,the structure has been continuously optimized,and the policy system has been continuously improved. However,it is also necessary to further improve the specialization and standardization of pharmaceutical supply chain services,further improve the master data management information system of pharmaceutical circulation supply chain,further optimize the layout of pharmaceutical logistics network,and improve the consistency of provincial pharmaceutical circulation supervision policies. In the future,we need to take the medical circulation enterprises to increase the service value and reduce the service cost as the fundamental starting point and objutive and vigorously promote the service innovation of the medical circulation industry through the cooperation of the government,industry associations and enterprises,so as to better help the medical circulation industry improve the service quality,reduce the cost and increase the efficiency,and achieve high-quality development.
<<Keywords: | Development and SecurityPharmaceutical CirculationHigh-quality DevelopmentDual Circulation |